• Epileptic Center, Guangdong 999 Brain Hospital, Guang zhou 510510, Guangdong, China;
OUYangmei, Email: oymsunny@sina.com
Export PDF Favorites Scan Get Citation

Objective To study the clinical characteristics of patients onset epilepsy Dentatorubral-pallidoluysian atropy (DRPLA) in Epilepsy Center of Guangdong 999 Brain Hospital and improve understanding of the disease. Methods Collected five patients from August 2014 to August 2016 in Guangdong 999 Brain Hospital, whom diagnosed through genetic testing of DRPLA, analysed their disease course, family history, video-EEG, brain MRI and treatment data. Results DRPLA performed as neurodegenerative diseases, and epilepsy population mainly performed as progressive myoclonic epilepsy (Progressive myoclonus epilepsy, PME). Conclusion DRPLA is autosomal dominant neurodegenerative disease. In patients with cerebellar atrophy, neurological regression, ataxia, drug refractory epilepsy, it is recommended routinely to detect ATN1 gene, so that timely diagnosis and genetic counseling.

Citation: OUYangmei, FEILingxia, LIHua, HUXiangshu, ZHANGPeiqi, LONGQiting, LIUXinzhou. Clinical study about the patients onset epilepsy diaginose of Dentatorubral-pallidoluysian atropy. Journal of Epilepsy, 2016, 2(6): 488-493. doi: 10.7507/2096-0247.20160086 Copy

  • Previous Article

    Clinical features and progress of catamenial epilepsy-with 20 cases reported
  • Next Article

    The clinical analysis of senile epilepsy